Does ZOMETA Cause Second primary malignancy? 64 Reports in FDA Database

Q: Does ZOMETA cause Second primary malignancy?

64 reports of Second primary malignancy have been filed with the FDA for ZOMETA, representing 7.4% of all ZOMETA adverse event reports.

Q: How dangerous is Second primary malignancy from ZOMETA?

Of 64 reports, 20 (31.3%) resulted in death and 37 required hospitalization.

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 64 reports of Second primary malignancy have been filed in association with ZOMETA. This represents 7.4% of all adverse event reports for ZOMETA.

Reports of Second primary malignancy with ZOMETA

7.4%

of all ZOMETA reports

Deaths

Hospitalizations

How Dangerous Is Second primary malignancy From ZOMETA?

Of the 64 reports, 20 (31.3%) resulted in death, 37 (57.8%) required hospitalization, and 1 (1.6%) were considered life-threatening.

Is Second primary malignancy Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ZOMETA. However, 64 reports have been filed with the FAERS database.

What Other Side Effects Does ZOMETA Cause?

Osteonecrosis of jaw (386) Pain (234) Anxiety (195) Dyspnoea (169) Spinal osteoarthritis (166) Osteoarthritis (160) Arthralgia (156) Exposed bone in jaw (153) Osteomyelitis (152) Death (147)

What Other Drugs Cause Second primary malignancy?

CYCLOPHOSPHAMIDE (1,247) DOXORUBICIN (1,151) VINCRISTINE (908) IMATINIB (763) PALBOCICLIB (658) RITUXIMAB (646) RUXOLITINIB (611) ETOPOSIDE (573) PREDNISONE (517) OCTREOTIDE (496)

Which ZOMETA Alternatives Have Lower Second primary malignancy Risk?

ZOMETA vs ZONISAMIDE ZOMETA vs ZOPICLONE ZOMETA vs ZOTEPINE ZOMETA vs ZUCLOPENTHIXOL ZOMETA vs ZUCLOPENTHIXOL DECANOATE

ZOMETA Full Profile All Second primary malignancy Reports All Drugs Causing Second primary malignancy ZOMETA Demographics